日本疫苗全生命周期监管模式的经验与启示

    Experience and Enlightenment of Japan's Vaccine Life-cycle Regulation Model

    • 摘要:
      目的  对日本疫苗全生命周期监管模式进行研究,探讨其对中国疫苗全生命周期监管体系优化的参考价值。
      方法 采用文献研究法,通过查阅中英文文献、官方政策、报告等对日本疫苗监管体系及全生命周期监管模式进行梳理归纳。
      结果 日本建立了覆盖疫苗研发、生产、流通及上市后监测全过程的法规制度体系,并通过落实监管主体责任、应用冷链运输技术及构建信息共享机制和平台等,形成较为合理、高效的疫苗全生命周期监管模式。
      结论 中国可借鉴日本经验,健全疫苗监管法规制度,尤其是紧急使用制度和疫苗接种损害补偿制度;充分发挥各方监管力量,并落实相关主体责任;从流程简化、监管队伍专业能力提升及技术引进等方面提升监管效能;完善信息共享平台和机制,以强化中国疫苗全生命周期监管能力。

       

      Abstract:
      OBJECTIVE  To study the whole life cycle regulation model of vaccine in Japan, and to explore its reference for optimizing the whole life cycle regulation system of vaccine in China.
      METHODS  Using the literature research method, the Japanese vaccine regulatory system and the whole life cycle regulation model were sorted out and summarized by reviewing Chinese and English literature, official policies, reports, etc.
      RESULTS  Japan had established a regulatory system that covered the whole process of vaccine research and development, production, circulation and post-marketing; and had formed a relatively reasonable and efficient vaccine life cycle regulation model by implementating regulatory responsibilities, applying cold chain transportation technology, and building information sharing mechanisms and platforms.
      CONCLUSION  China can learn from Japan's experience and improve the regulatory system for vaccine, especially the emergency use system and the vaccination damage compensation system; give full play to the regulatory power of all parties and implement the responsibilities of relevant entities; enhance regulatory efficiency in terms of process simplification, professional capacity enhancement of the regulatory team, and technology introduction; improve the information sharing platform and mechanism to strengthen China's ability to regulate the whole life cycle of vaccine.

       

    /

    返回文章
    返回